Literature DB >> 2806241

Molecular and cellular studies of tryptophanyl-tRNA synthetases using monoclonal antibodies. Remarkable variations in the content of tryptophanyl-tRNA synthetase in the pancreas of different mammals.

O O Favorova1, T A Zargarova, V S Rukosuyev, S F Beresten, L L Kisselev.   

Abstract

The content of Trp-tRNA synthetase in pancreas and liver of cattle, sheep, swine, rat, rabbit and man was assayed by direct radioimmunoblotting with a 125I-labelled monoclonal antibody Am1, specifically interacting with any eukaryotic Trp-tRNA synthetase. Its content in the organs studied, with the exception of bovine and sheep pancreas, was found to be 0.002-0.012% of total proteins. The enzyme content in bovine pancreas was about 0.2% of total proteins, i.e. 70 times higher than in bovine liver; similar correlations were found for sheep. The Trp-tRNA synthetase levels in each organ varied from animal to animal of the same species by not more than a factor of four; these individual variations cannot affect the conclusion about the profound differences in the levels of the enzyme in pancreases of Ruminantia and of the other mammalians. As shown by indirect immunofluorescence technique, bovine Trp-tRNA synthetase is mainly located in the exocrine part of the pancreas. Moreover, the immunoreactive material is detectable also in bovine (not human) pancreatic juice. The abnormally high Trp-tRNA synthetase content in the ruminant pancreas may be connected with unknown function(s) of this protein somehow related to the peculiarities of digestion of these mammals.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2806241     DOI: 10.1111/j.1432-1033.1989.tb15053.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  Tryptamine induces tryptophanyl-tRNA synthetase-mediated neurodegeneration with neurofibrillary tangles in human cell and mouse models.

Authors:  Elena L Paley; Galina Denisova; Olga Sokolova; Natalia Posternak; Xukui Wang; Anna-Liisa Brownell
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

2.  Hormonal activity of AIMP1/p43 for glucose homeostasis.

Authors:  Sang Gyu Park; Young Sun Kang; Jin Young Kim; Chang Seok Lee; Young Gyu Ko; Woo Je Lee; Ki-Up Lee; Young Il Yeom; Sunghoon Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-25       Impact factor: 11.205

3.  A human aminoacyl-tRNA synthetase as a regulator of angiogenesis.

Authors:  Keisuke Wakasugi; Bonnie M Slike; John Hood; Atsushi Otani; Karla L Ewalt; Martin Friedlander; David A Cheresh; Paul Schimmel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

4.  A new gamma-interferon-inducible promoter and splice variants of an anti-angiogenic human tRNA synthetase.

Authors:  Jianming Liu; Eveline Shue; Karla L Ewalt; Paul Schimmel
Journal:  Nucleic Acids Res       Date:  2004-02-02       Impact factor: 16.971

Review 5.  Tryptophanyl-tRNA Synthetase as a Potential Therapeutic Target.

Authors:  Young Ha Ahn; Se-Chan Oh; Shengtao Zhou; Tae-Don Kim
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

6.  Identification of a residue crucial for the angiostatic activity of human mini tryptophanyl-tRNA synthetase by focusing on its molecular evolution.

Authors:  Terumasa Nakamoto; Miki Miyanokoshi; Tomoaki Tanaka; Keisuke Wakasugi
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.